Thermo Fisher Scientific (TMO)
NYSE • Healthcare
February 17, 2026 at 21:00 UTC
Name
CEO
Website
Industry
Year Founded
Employees
Thermo Fisher Scientific Inc. is a life-science tools and services company that helps laboratories, manufacturers, and health systems turn experiments into routine outcomes. It supplies technology and know-how for sample preparation, measurement, and regulated production, with delivery models that range from instruments on site to outsourced scientific services. The approach is practical: keep methods consistent, documentation clear, and supply reliable so work can move from discovery to everyday use without constant reinvention. Teams support customers in research, diagnostics, and bioproduction, aligning procedures with standards that travel across regions. By pairing science with service, the company positions itself as infrastructure for modern laboratories and plants rather than a single product bet, aiming to make complex workflows feel predictable in real settings.
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Thermo Fisher Scientific's Technical Indicators Summary
TMO is currently trading just above its key moving averages, including the 10-day and 200-day EMAs, which generally indicates a bullish trend. Momentum indicators such as the MACD and short-term moving averages support this positive outlook, while the RSI and CCI remain in moderate territory, suggesting neither overbought nor oversold conditions. However, the ADX near 24 points to only a modest trend strength, and the declining On-Balance Volume signals some selling pressure despite stable price levels. Volatility, as measured by the ATR, remains steady, and with the session closed, there is no VWAP data to influence intraday interpretation. Overall, the technical landscape for TMO reflects a balanced stance between upward momentum and caution from volume dynamics.
| Indicator | Value |
|---|---|
RSI (14) | 61.89 |
Stochastic %K (14, 3, 3) | 85.66 |
CCI (20) | 90.10 |
WPR (14) | -21.09 |
Momentum (10) | 26.21 |
MFI | 67.25 |
MACD Level (12, 26) | 12.21 |
Bollinger Bands | $556.22 - $638.61 |
ATR (14) | $13.64 (2.21%) |
ADX (14) | 24.02 |
OBV | -20,673,400 |
Exponential Moving Averages | $522.23 - $612.59(5 indicators) |
Simple Moving Averages | $490.88 - $616.22(5 indicators) |
Get premium market insights delivered directly to your inbox.
By the bell, TMO was still trading below yesterday, reflecting a -0.675% opening gap down and a close near 501.41. By the close, the sector was essentially flat at -0.16%, leaving stock-specific drivers to dominate. TMO is trading amid limited headlines with recent sector flat, influenced by strong earnings and market forecasts.
Price Change
from $504.82 close
-$3.41
Trading Volume
Above avg 2.8M
3.2M
vs S&P 500 Today
Strong Underperformance
-3.56%
52-Week Position
Mid-range
44.8%
Updated: February 17, 2026 at 21:04 UTC
Thermo Fisher prices $3.8B notes for Clario deal
February 10, 2026
AI boom powers chips, storage, and lab-tech deals
January 18, 2026